HHS-FDA

Food and Drug Administration Grants

43 active funding opportunities from Food and Drug Administration.

43

Active Grants

$0

Total Funding

1

Categories

Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives Clinical Trials Not Allowed

342d leftApr 1, 2027

NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens

342d leftApr 1, 2027

Laboratory Flexible Funding Model (LFFM)

627d leftJan 11, 2028

Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)

655d leftFeb 8, 2028

Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)

753d leftMay 16, 2028

Vet-LIRN Capacity-Building Project and Equipment Grants (U18)

864d leftSep 4, 2028

Integrating Machine Learning with Computational Fluid Dynamics Models of Orally Inhaled Drug Products (U01) Clinical Trials Not Allowed

Clinical Trials Addressing Unmet Needs of Rare Neurodegenerative Diseases (R01) Clinical Trials Required

Development and Maintenance of Human and Animal Food Rapid Response Teams (U2F) Clinical Trials Not Allowed

Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed

FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)

Center for Research on Complex Generics (U18) Clinical Trials Optional

Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed

FDA's Integrated Food Safety System Training Delivery and Development

Minor Use Minor Species Development of Drugs (R01)

Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)

Cooperative Agreement to Support a Human Abuse Potential Study of Botanical Kratom (U01 Clinical Trial Required)

Developing PBPK Model-Based Mechanistic IVIVCs for Long Acting Injectable Suspensions and Implants (U01) Clinical Trial Optional

Studies Addressing Rare Neurodegenerative Diseases including ALS

Cooperative Agreement to Support Activities Related to Analgesics, Anesthetics, and Addiction (U01) Clinical Trials Allowed

NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens

FDA OMHHE Health Equity Innovation Award: Enhance Equity Funding Opportunity (U01) Clinical Trials Not Allowed

Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)

Federal and State Integration Activities to Advance Cooperation and Regulatory Standards Among Animal Food Safety Regulatory Programs

Data Standards for Tobacco Research and Scientific Review Phase 2

Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Required)

Applied regulatory science research to evaluate and treat cardiotoxicity of oncology therapeutics

Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed

Animal Food Regulatory Program Alliance

Retail Food Safety Regulatory Association Collaboration CAP

FDA OMHHE Convener for Racial & Ethnic minority Acceleration Consortium for Health Equity (REACH)

Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical Trial Not Allowed

Cooperative Agreement for Long Term Data Collection on Antimicrobial Use in Animals (U01) Clinical Trial Not Allowed

Food Safety Capacity and Infrastructure Building (U2F)

Manufactured Foods Flexible Funding Model (MF-FFM)

Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)

Improving Predictability of Food-Drug and Drug-Drug Interaction Risks by Utilizing In Vitro Simulated Gastrointestinal Dissolution Model for High-Risk Oral Drug Products (U01) Clinical Trial Optional

Conformance with the Egg Regulatory Program Standards

Identification of Drug-related and Formulation-Related Factors that Result in Alcohol Dose Dumping of Modified Release Oral Drug Products (U01) Clinical Trial Not Allowed

Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives

Reducing Fraud and Lowering Barriers to the Production of Drugs in Shortage by Outsourcing Facilities

REACHing Communities (REACH) Consortium (U01) Clinical Trials Optional

OMHHE Educational Funding Opportunity: Expanding education on skin lightening products (U01) Clinical Trials Not Allowed

Track Food and Drug Administration grants automatically

Create a free account to get alerts when new grants are posted, track deadlines, and get AI-powered matching.

Get Started Free